Covalent control of 6‐phosphofructo‐2‐kinase/fructose‐2,6‐bisphosphatase: Insights into autoregulation of a bifunctional enzyme
- 1 June 1995
- journal article
- review article
- Published by Wiley in Protein Science
- Vol. 4 (6) , 1023-1037
- https://doi.org/10.1002/pro.5560040601
Abstract
The hepatic bifunctional enzyme, 6‐phosphofructo‐2‐kinase/fructose‐2,6‐bisphosphatase (6PF‐2‐K/Fru‐2,6‐P2ase), E.C. 2–7–1–105/E.C. 3–1–3–46, is one member of a family of unique bifunctional proteins that catalyze the synthesis and degradation of the regulatory metabolite fructose‐2,6‐bisphosphate (Fru‐2,6‐P2). Fru‐2,6‐P2 is a potent activator of the glycolytic enzyme 6‐phosphofructo‐1‐kinase and an inhibitor of the gluconeogenic enzyme fructose‐1,6‐bisphosphatase, and provides a switching mechanism between these two opposing pathways of hepatic carbohydrate metabolism. The activities of the hepatic 6PF‐2‐K/Fru‐2,6‐P2ase isoform are reciprocally regulated by a cyclic AMP‐dependent protein kinase (cAPK)‐catalyzed phosphorylation at a single NH2‐terminal residue, Ser‐32. Phosphorylation at Ser‐32 inhibits the kinase and activates the bisphosphatase, in part through an electrostatic mechanism. Substitution of Asp for Ser‐32 mimics the effects of cAPK‐catalyzed phosphorylation. In the dephosphorylated homodimer, the NH2‐ and COOH‐terminal tail regions also have an interaction with their respective active sites on the same subunit to produce an autoregulatory inhibition of the bisphosphatase and activation of the kinase. In support of this hypothesis, deletion of either the NH2‐ or COOH‐terminal tail region, or both regions, leads to a disruption of these interactions with a maximal activation of the bisphosphatase. Inhibition of the kinase is observed with the NH2‐truncated forms, in which there is also a diminution of cAPK phosphorylation to decrease the Km for Fru‐6‐P. Phosphorylation of the bifunctional enzyme by cAPK disrupts these autoregulatory interactions, resulting in inhibition of the kinase and activation of the bisphosphatase. Therefore, effects of cyclic AMP‐dependent phosphorylation are mediated by a combination of electrostatic and autoregulatory control mechanisms.Keywords
This publication has 93 references indexed in Scilit:
- Cloning and Expression of a Catalytic Core Bovine Brain 6-Phosphofructo-2-Kinase/Fructose-2,6-BisphosphataseBiochemical and Biophysical Research Communications, 1995
- Lack of Evidence for a Role of Cys-138 as a Base Catalyst in the Skeletal Muscle 6-Phosphofructo-2-kinase ReactionBiochemical and Biophysical Research Communications, 1993
- Isolation of a cDNA for Chicken Liver 6-Phosphofructo-2-Kinase/Fructose-2,6-BisphosphataseBiochemical and Biophysical Research Communications, 1993
- Structural basis of the allosteric behaviour of phosphofructokinaseNature, 1990
- Isolation of a cDNA clone for rat liver 6-phosphofructo 2-kinase/fructose 2,6-bisphosphataseBiochemical and Biophysical Research Communications, 1987
- Characterization of the exchange reactions of rat liver 6-phosphofructo 2-kinase/fructose 2,6-bisphosphataseBiochemical and Biophysical Research Communications, 1984
- Cyclic AMP-dependent phosphorylation of rat liver 6-phosphofructo 2-kinase/fructose 2,6-bisphosphataseBiochemical and Biophysical Research Communications, 1982
- Inactivation of phosphofructokinase 2 by cyclic AMP-dependent protein kinaseBiochemical and Biophysical Research Communications, 1981
- Partial purification of a rat liver enzyme that catalyzes the formation of fructose 2,6-bisphosphateBiochemical and Biophysical Research Communications, 1981
- Relation between structure and function of α/β–protejnsQuarterly Reviews of Biophysics, 1980